EYES Insider Trading Activity and SEC Form 4 Filings
EYES insider trading summary
No open-market insider purchases or sales of Second Sight Medical Products Inc (EYES) have been reported on SEC Form 4 in the past 12 months.
Latest EYES insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 14, 2022 | Gregg Williams | Director | Buy | $200 (100 @ $2.00) |
| Jun 13, 2022 | Gregg Williams | Director | Buy | $7K (3,700 @ $2.00) |
| Jun 3, 2022 | Gregg Williams | Director | Buy | $10K (3,960 @ $2.46) |
| Jun 2, 2022 | Gregg Williams | Director | Buy | $246K (105,162 @ $2.34) |
| Jun 1, 2022 | Gregg Williams | Director | Buy | $299K (132,461 @ $2.26) |
| May 31, 2022 | Gregg Williams | Director | Buy | $174K (74,870 @ $2.33) |
| May 24, 2022 | Gregg Williams | Director | Buy | $110K (55,438 @ $1.98) |
| May 23, 2022 | Gregg Williams | Director | Buy | $329K (167,160 @ $1.97) |
| May 20, 2022 | Gregg Williams | Director | Buy | $590K (307,649 @ $1.92) |
| May 19, 2022 | Gregg Williams | Director | Buy | $196K (108,794 @ $1.80) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.